Canopy Biosciences offers a comprehensive portfolio of products and services for spatial biology, multi-omics, and bioprocessing. Canopy’s technologies include ChipCytometry for precise spatial multiplexing in cells and tissue samples, ultrasensitive DNA sequencing (RareSeq), RNA-Seq, and gene expression analysis. Canopy was acquired by Bruker Corporation (Nasdaq: BRKR) in 2020. Additional information is available at www.canopybiosciences.com.